Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
Portfolio Pulse from
Sernova Biotherapeutics has appointed Dr. Pericles Calias as Chief Development Officer and Head of R&D. Dr. Calias is expected to bring operational depth and cell therapy expertise to the company.
March 10, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sernova Biotherapeutics has appointed Dr. Pericles Calias as Chief Development Officer and Head of R&D, which could enhance the company's operational capabilities and cell therapy expertise.
The appointment of Dr. Calias is likely to positively impact Sernova's operational capabilities and expertise in cell therapy, which could lead to advancements in their R&D efforts and potentially improve their market position.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100